{"id":"https://openalex.org/W4412426592","doi":"https://doi.org/10.1080/2162402x.2025.2520269","title":"An immunological mechanism of resistance to CDK4/6 inhibitors in HR + breast cancer","display_name":"An immunological mechanism of resistance to CDK4/6 inhibitors in HR + breast cancer","publication_year":2025,"publication_date":"2025-07-15","ids":{"openalex":"https://openalex.org/W4412426592","doi":"https://doi.org/10.1080/2162402x.2025.2520269","pmid":"https://pubmed.ncbi.nlm.nih.gov/40662849","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12269697"},"language":"en","primary_location":{"id":"doi:10.1080/2162402x.2025.2520269","doi":"https://doi.org/10.1080/2162402x.2025.2520269","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2025.2520269","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2025.2520269?needAccess=true","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2025.2520269?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Claudia Galassi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudia Galassi","raw_affiliation_strings":["Weill Cornell Medical College","Department of Pharmacology, Weill Cornell Medical College, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medical College","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"Department of Pharmacology, Weill Cornell Medical College, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033879297","display_name":"Giulia Petroni","orcid":"https://orcid.org/0000-0002-0558-5322","observed_orcids":["https://orcid.org/0000-0002-0558-5322"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Petroni","raw_affiliation_strings":["University of Florence","Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florence","institution_ids":["https://openalex.org/I45084792"]},{"raw_affiliation_string":"Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114020144","display_name":"Simon Knott","orcid":"https://orcid.org/0000-0002-4018-7653","observed_orcids":["https://orcid.org/0000-0002-4018-7653"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Simon R.V. Knott","raw_affiliation_strings":["Cedars-Sinai Medical Center","Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA"],"raw_orcid":"https://orcid.org/0000-0002-4018-7653","affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center","institution_ids":["https://openalex.org/I1282927834"]},{"raw_affiliation_string":"Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071827163","display_name":"Lorenzo Galluzzi","orcid":"https://orcid.org/0000-0003-2257-8500","observed_orcids":["https://orcid.org/0000-0003-2257-8500"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lorenzo Galluzzi","raw_affiliation_strings":["Fox Chase Cancer Center","Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA"],"raw_orcid":"https://orcid.org/0000-0003-2257-8500","affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5071827163","https://openalex.org/A5114020144"],"corresponding_institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I1289437631"],"apc_list":{"value":2375,"currency":"GBP","value_usd":2913},"apc_paid":{"value":2375,"currency":"GBP","value_usd":2913},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"1","first_page":"2520269","last_page":"2520269"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.062300000339746475,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.022600000724196434,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7319999933242798},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.8629999756813049},{"id":"https://openalex.org/keywords/gamma-delta-t-cells","display_name":"\u03b3\u03b4 T cells","score":0.8299999833106995},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":0.8100000023841858},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.8270000219345093},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cx3cr1","display_name":"CX3CR1","score":0.8569999933242798},{"id":"https://openalex.org/keywords/macrophage-repolarization","display_name":"macrophage repolarization","score":0.8220000267028809},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7940000295639038},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.9710000157356262}],"concepts":[{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.653322160243988},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6206936836242676},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.619103193283081},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5428500175476074},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5181418657302856},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37733832001686096},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3408603072166443},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28481101989746094},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000075942","descriptor_name":"Intraepithelial Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000084582","descriptor_name":"Tumor-Associated Macrophages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000084582","descriptor_name":"Tumor-Associated Macrophages","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051358","descriptor_name":"Cyclin-Dependent Kinase 4","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051361","descriptor_name":"Cyclin-Dependent Kinase 6","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1080/2162402x.2025.2520269","doi":"https://doi.org/10.1080/2162402x.2025.2520269","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2025.2520269","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2025.2520269?needAccess=true","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12269697","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12269697","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Text"},{"id":"pmid:40662849","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40662849","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Editorial"},{"id":"pmh:oai:doaj.org/article:ef0ebb708d594d0ea66f719070394d27","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ef0ebb708d594d0ea66f719070394d27","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoImmunology, Vol 14, Iss 1 (2025)","raw_type":"article"},{"id":"pmh:oai:flore.unifi.it:2158/1450171","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2158/1450171","pdf_url":null,"source":{"id":"https://openalex.org/S4306402033","display_name":"Florence Research (University of Florence)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45084792","host_organization_name":"University of Florence","host_organization_lineage":["https://openalex.org/I45084792"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1080/2162402x.2025.2520269","doi":"https://doi.org/10.1080/2162402x.2025.2520269","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2025.2520269","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2025.2520269?needAccess=true","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1462752421","display_name":null,"funder_award_id":"ZP-6177","funder_id":"https://openalex.org/F4320332898","funder_display_name":"Stand Up To Cancer"},{"id":"https://openalex.org/G2877016160","display_name":null,"funder_award_id":"ZP-6177","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3500543458","display_name":null,"funder_award_id":"ZP-6177","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G489133006","display_name":null,"funder_award_id":"#I16-0064","funder_id":"https://openalex.org/F3581174656","funder_display_name":"Starr Cancer Consortium"},{"id":"https://openalex.org/G5946283803","display_name":null,"funder_award_id":"-6177","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000885128","display_name":"Dynamics of Immune Response in Irradiated Rectal Cancer","funder_award_id":"U54CA274291","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000907107","display_name":"Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer","funder_award_id":"R01CA271915","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F3581174656","display_name":"Starr Cancer Consortium","ror":null},{"id":"https://openalex.org/F4320308295","display_name":"Leukemia and Lymphoma Society","ror":"https://ror.org/04m0xav37"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332513","display_name":"Weill Cornell Medical College","ror":"https://ror.org/02r109517"},{"id":"https://openalex.org/F4320332898","display_name":"Stand Up To Cancer","ror":"https://ror.org/01dmpb598"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4412426592.pdf","grobid_xml":"https://content.openalex.org/works/W4412426592.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W2005895632","https://openalex.org/W2044748328","https://openalex.org/W2126043518","https://openalex.org/W3020753817","https://openalex.org/W3045997924","https://openalex.org/W3099482482","https://openalex.org/W3125893929","https://openalex.org/W3128687890","https://openalex.org/W4220829656","https://openalex.org/W4220955524","https://openalex.org/W4284693043","https://openalex.org/W4389558851","https://openalex.org/W4399300859","https://openalex.org/W4402639290","https://openalex.org/W4403299725","https://openalex.org/W4412093921"],"related_works":["https://openalex.org/W4412093921","https://openalex.org/W4308399153","https://openalex.org/W4411290015","https://openalex.org/W4415236825","https://openalex.org/W3213731871","https://openalex.org/W4224871294","https://openalex.org/W7154479659","https://openalex.org/W4376613791","https://openalex.org/W4415131858","https://openalex.org/W7162668132"],"abstract_inverted_index":{"CDK4/6":[0,32],"inhibitors":[1],"are":[2],"central":[3],"to":[4,23,45],"the":[5,24],"clinical":[6],"management":[7],"of":[8],"HR+HER2\u2212":[9],"breast":[10],"cancer.":[11],"We":[12],"have":[13],"recently":[14],"demonstrated":[15],"that":[16],"immunosuppressive,":[17],"IL17-secreting":[18],"\u03b3\u03b4":[19],"T":[20],"cells":[21],"recruited":[22],"tumor":[25],"microenvironment":[26],"by":[27],"a":[28,39],"CCL2-dependent":[29],"mechanism":[30],"upon":[31],"inhibition":[33],"can":[34],"repolarize":[35],"tumor-associated":[36],"macrophages":[37],"toward":[38],"CX3CR1+":[40],"phenotype":[41],"associated":[42],"with":[43],"resistance":[44],"therapy.":[46]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2025-07-15T00:00:00"}